NVCR icon

NovoCure

301 hedge funds and large institutions have $6.33B invested in NovoCure in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 94 increasing their positions, 103 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

19% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 43

27% less call options, than puts

Call options by funds: $76.8M | Put options by funds: $105M

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
301
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$76.8M
Puts
$105M
Net Calls
Net Calls Change

Top Buyers

1 +$220M
2 +$81M
3 +$25.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.81M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$5.92M

Top Sellers

1 -$58M
2 -$26.7M
3 -$20.7M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$15.4M
5
Two Sigma Investments
Two Sigma Investments
New York
-$9.29M
Name Holding Trade Value Shares
Change
Change in
Stake
226
$57K
227
$54K
228
$42K
229
$39K
230
$38K
231
$38K
232
$37K
233
$37K
234
$32K
235
$31K
236
$30K
237
$24K
238
$21K
239
$18K
240
$18K
241
$17K
242
$15K
243
$15K
244
$15K
245
$13K
246
$12K
247
$11K
248
$10K
249
$10K
250
$9K